細胞培養基市場規模、佔有率及成長分析（依產品、應用、培養基類型、最終用途及地區分類）－2026-2033年產業預測

全球細胞培養基市場規模預計在 2024 年達到 62.3 億美元，從 2025 年的 72.3 億美元成長到 2033 年的 237.3 億美元，在預測期（2026-2033 年）內複合年成長率為 16.02%。

全球細胞培養基市場正經歷顯著成長，這主要得益於各行業對招募自動化解決方案的日益普及。企業和政府機構正擴大採用整合式機器學習和人工智慧的先進系統來提高招募效率。這些解決方案利用自然語言處理和數據分析來簡化篩選流程，有效減少人工篩選中常見的錯誤和偏見。申請人追蹤系統 (ATS) 的需求不斷成長，其優勢在於能夠更快、更準確地處理申請，同時降低人事費用。銀行、醫療保健、製造業和電信等行業正在利用這些創新工具來改善人才招聘，這凸顯了勞動力管理自動化更廣泛的趨勢。

全球細胞培養基市場促進因素

全球細胞培養基市場的發展主要得益於研究人員不斷創新，致力於提升細胞培養基在各種臨床應用中的效能。白蛋白是生產必需單株抗體和重組蛋白的關鍵成分，它在結合和穩定重要小分子和離子方面發揮著至關重要的作用，從而確保生產過程的穩定性。因此，在培養基中添加重組哺乳動物白蛋白有望顯著推動市場成長並提高產品產量。未來，採用此類先進調查方法可望進一步促進市場擴張。

全球細胞培養基市場面臨的限制因素

全球細胞培養基市場面臨嚴峻挑戰，尤其是在中低收入國家，品管系統的不足尤為突出。這些地區資源匱乏，難以妥善儲存和維護細胞培養基，迫使其依賴可能無法滿足嚴格品質標準的簡易設備。這種情況往往導致污染水平升高，從而損害培養基的整體品質和可靠性。因此，先進設備和高效流程的匱乏對細胞培養的有效性產生了負面影響，並成為限制該細分市場成長和發展的重大阻礙因素。

全球細胞培養基市場趨勢

受基因療法的廣泛應用和發展所推動，全球細胞培養基市場正經歷顯著成長。隨著基因療法在治療多種獲得性和遺傳性神經系統疾病的應用日益普及，用於支持基因產物開發和生產的專用培養基需求激增，這些基因產物能夠緩解細胞功能障礙。全球持續進行的基因療法新應用研發工作預計將進一步推動對高品質細胞培養基的需求，這反映了生命科學領域向創新療法發展的整體趨勢。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管分析

全球細胞培養基市場規模（按產品和複合年成長率分類）（2026-2033 年）

• 無血清培養基
  • CHO培養基
  • BHK 中等
  • Vero 中等
  • HEK 293 中等大小
  • 其他無血清培養基
• 傳統媒體
• 幹細胞培養基
• 特殊培養基
• 化學成分明確的培養基
• 其他細胞培養基

全球細胞培養基市場規模（依應用及複合年成長率分類）（2026-2033 年）

• 生物製藥生產
  • 單株抗體
  • 疫苗生產
  • 其他治療性蛋白質
  • 診斷
• 藥物篩檢與開發
• 組織工程與再生醫學
  • 細胞和基因治療
  • 其他組織工程及再生醫學應用
• 其他用途

全球細胞培養基市場規模（按培養基類型和複合年成長率分類）（2026-2033 年）

• 液體介質
• 半固態和固態介質

全球細胞培養基市場規模（按最終用途和複合年成長率分類）（2026-2033 年）

• 製藥和生物技術公司
• 醫院和診斷檢查室
• 研究和學術機構
• 其他用途

全球細胞培養基市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Thermo Fisher Scientific Inc.（USA）
• Merck KGaA（Germany）
• Cytiva（USA）
• Lonza Group Ltd.（Switzerland）
• Sartorius AG（Germany）
• Fujifilm Irvine Scientific, Inc.（USA）
• Corning Incorporated（USA）
• Bio-Techne Corporation（USA）
• PromoCell GmbH（Germany）
• CellGenix GmbH（Germany）
• Takara Bio Inc.（Japan）
• HiMedia Laboratories Pvt. Ltd.（India）
• Zenbio, Inc.（USA）
• Biological Industries（Israel）
• Cook Medical（USA）
• Stemcell Technologies Inc.（Canada）
• Serumwerk Bernburg AG（Germany）
• AthenaES（USA）
• Biochrom GmbH（Germany）
• Pan-Biotech GmbH（Germany）

結論與建議

Global Cell Culture Media Market size was valued at USD 6.23 Billion in 2024 and is poised to grow from USD 7.23 Billion in 2025 to USD 23.73 Billion by 2033, growing at a CAGR of 16.02% during the forecast period (2026-2033).

The Global Cell Culture Media market is witnessing significant growth driven by the increasing adoption of recruitment automation solutions across various sectors. Businesses and government entities are turning to advanced systems that integrate machine learning and artificial intelligence to enhance hiring efficiency. These solutions streamline the screening process by utilizing natural language processing and data analytics, effectively reducing human error and bias often present in manual reviews. The demand for applicant tracking systems (ATS) is rising, as they facilitate faster and more accurate processing of applications while simultaneously lowering labor costs. Industries including banking, healthcare, manufacturing, and telecommunications are leveraging these innovative tools to improve talent acquisition, highlighting a broader trend towards automation in workforce management.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Culture Media market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Culture Media Market Segments Analysis

Global Cell Culture Media Market is segmented by Product, Application, Media Type, End Use and region. Based on Product, the market is segmented into Serum-free Media, Classical Media, Stem Cell Culture Media, Specialty Media, Chemically Defined Media and Other Cell Culture Media. Based on Application, the market is segmented into Biopharmaceutical Production, Drug Screening and Development, Tissue Engineering andRegenerative Medicineand Other Applications. Based on Media Type, the market is segmented into Liquid Media and Semi-solid and Solid Media. Based on End Use, the market is segmented into Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Laboratories, Research and Academic Institutes and Other End Uses. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cell Culture Media Market

The Global Cell Culture Media market is fueled by the ongoing innovative efforts of researchers striving to enhance the effectiveness of cell culture media for various clinical applications. A critical component in the production of essential monoclonal antibodies and recombinant proteins is albumin, which plays a pivotal role in binding and stabilizing vital small molecules and ions, ensuring stability in manufacturing processes. Consequently, the integration of recombinant mammalian albumin supplements into culture media is expected to significantly drive market growth and improve product yields. The adoption of these advanced methodologies is likely to further propel the expansion of the market moving forward.

Restraints in the Global Cell Culture Media Market

The Global Cell Culture Media market faces significant challenges stemming from the inadequacies in quality management systems, particularly in low and middle-income countries. In these regions, resource limitations hinder the proper storage and maintenance of cell culture media, resulting in reliance on basic instruments that may not meet rigorous quality standards. This situation often leads to increased contamination levels, compromising the overall quality and reliability of the culture media. Consequently, the lack of advanced equipment and efficient processes has a detrimental impact on the effectiveness of cell culture practices, highlighting a critical restraint in the growth and advancement of this market segment.

Market Trends of the Global Cell Culture Media Market

The global cell culture media market is witnessing significant growth driven by the increasing acceptance and advancements in gene therapies. As gene therapies become more prevalent for treating a broad spectrum of acquired and inherited neurological disorders, the need for specialized cell culture media has surged to support the development and production of gene products that mitigate cellular dysfunction. With ongoing global research and development efforts aimed at discovering novel applications for gene therapy, the demand for high-quality cell culture media is poised to expand, reflecting the overall trend toward innovative therapeutic approaches in the life sciences sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis

Global Cell Culture Media Market Size by Product & CAGR (2026-2033)

• Market Overview
• Serum-free Media
  • CHO Media
  • BHK Medium
  • Vero Medium
  • HEK 293 Media
  • Other Serum-free media
• Classical Media
• Stem Cell Culture Media
• Specialty Media
• Chemically Defined Media
• Other Cell Culture Media

Global Cell Culture Media Market Size by Application & CAGR (2026-2033)

• Market Overview
• Biopharmaceutical Production
  • Monoclonal Antibodies
  • Vaccines Production
  • Other Therapeutic Proteins
  • Diagnostics
• Drug Screening and Development
• Tissue Engineering and Regenerative Medicine
  • Cell and Gene Therapy
  • Other tissue engineering and regenerative medicine applications
• Other Applications

Global Cell Culture Media Market Size by Media Type & CAGR (2026-2033)

• Market Overview
• Liquid Media
• Semi-solid and Solid Media

Global Cell Culture Media Market Size by End Use & CAGR (2026-2033)

• Market Overview
• Pharmaceutical and Biotechnology Companies
• Hospitals and Diagnostic Laboratories
• Research and Academic Institutes
• Other End Uses

Global Cell Culture Media Market Size & CAGR (2026-2033)

• North America (Product, Application, Media Type, End Use)
  • US
  • Canada
• Europe (Product, Application, Media Type, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, Media Type, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, Media Type, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, Media Type, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytiva (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Irvine Scientific, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PromoCell GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CellGenix GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HiMedia Laboratories Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zenbio, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biological Industries (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stemcell Technologies Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Serumwerk Bernburg AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AthenaES (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biochrom GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pan-Biotech GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations